New study shows NICE Advice support can reduce appraisal timelines by 3 months
Companies who receive scientific advice from our NICE Advice service may experience a faster path to guidance publication, a study has found.
Companies who receive scientific advice from our NICE Advice service may experience a faster path to guidance publication, a study has found.
The guideline makes new recommendations and updates existing ones on diagnosing and managing a condition that affects approximately 1.5 million women of reproductive age in the UK.
Our updated guideline on menopause emphasises the importance of an individualised approach and shared decision-making when making choices about treatment for symptoms.
Around 5.3 million people in England were given a NICE-recommended statin or ezetimibe by their GP to help reduce their cholesterol during 2023/24, the largest number on record and almost 900,000 more than in 2022/23.
How we make independent decisions on the cost and clinical effectiveness of medicines and treatments.
How Clatterbridge Cancer Centre improved early detection rates of metatstatic spinal cord compression, and increased the average survival rates of patients through following our recommendations.
Our associate director of NICE Advice outlines his top tips for healthtech companies, helping them chart a clear path from innovation to NHS adoption.
Lead with confidence through our Executive MSc in Healthcare Decision-Making.